Guidelines in Practice: Medication Safety

被引:1
作者
Speth, Jennifer [1 ]
机构
[1] AORN Inc, Denver, CO 80231 USA
关键词
medication error; compounded medication; hazardous waste; beyond-use date; chemotherapy; DRUGS;
D O I
10.1002/aorn.14034
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Medication errors are preventable events that health care professionals, consumers, and medication manufacturers report to the US Food and Drug Administration. The agency receives more than 100,000 medication-related reports each year, and some reports involve patient death. A variety of sources provide perioperative nurses with information on interventions and practices to prevent medication errors, including the US Pharmacopeia, The Joint Commission, medication manufacturers' instructions for use, safety data sheets, and the updated AORN "Guideline for medication safety." This article provides an overview of the guideline and discusses recommendations for organizational oversight, procurement and storage, retrieval and preparation, labeling, and hazardous medications. It also includes a scenario that illustrates perioperative nursing practices for administering an antineoplastic medication intraoperatively. Perioperative nurses should review the guideline in its entirety and implement recommendations in operative or procedural settings.
引用
收藏
页码:380 / 389
页数:10
相关论文
共 24 条
  • [1] Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)?
    Ametsbichler, Paul
    Boehlandt, Antje
    Nowak, Dennis
    Schierl, Rudolf
    [J]. EJSO, 2018, 44 (11): : 1793 - 1799
  • [2] [Anonymous], Condition of participation: Infection prevention and con- trol and antibiotic stewardship programs. 42 CFR 482.42
  • [3] [Anonymous], 2009, FEDERAL FOOD DRUG CO
  • [4] [Anonymous], 2023, State Operations Manual Appendix A - Survey Protocol, Regula - tions and Interpretive Guidelines for Hospitals
  • [5] [Anonymous], 2019, Working to reduce medication errors
  • [6] [Anonymous], Hazard communication. 29 CFR 1910.1200.
  • [7] [Anonymous], 2017, FDAS HUM DRUG COMP P
  • [8] [Anonymous], PERSONAL PROTECTIVE
  • [9] [Anonymous], Hazardous drugs
  • [10] [Anonymous], 2024, Guidelines for Perioperative Practice